Alliance Pharma (LSE:APH) FCF Yield % : 15.26 (As of Apr. 29, 2024)

View and export this data going back to 2001. Start your Free Trial

What is Alliance Pharma FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Alliance Pharma's Trailing 12-Month Free Cash Flow is £28.8 Mil, and Market Cap is £188.9 Mil. Therefore, Alliance Pharma's FCF Yield % for today is 15.26%.

The historical rank and industry rank for Alliance Pharma's FCF Yield % or its related term are showing as below:

LSE:APH' s FCF Yield % Range Over the Past 10 Years
Min: -0.61 Med: 6.1 Max: 15.26
Current: 15.26

During the past 13 years, the highest FCF Yield % of Alliance Pharma was 15.26%. The lowest was -0.61%. And the median was 6.10%.

LSE:APH's FCF Yield % is ranked better than
94.45% of 1081 companies
in the Drug Manufacturers industry
Industry Median: -0.63 vs LSE:APH: 15.26

Alliance Pharma's FCF Margin % for the quarter that ended in Jun. 2023 was 18.75%.

Alliance Pharma FCF Yield % Historical Data

The historical data trend for Alliance Pharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alliance Pharma FCF Yield % Chart

Alliance Pharma Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

FCF Yield %

Get a 7-Day Free Trial

5.54

7.10

7.92

5.66

7.12

Alliance Pharma Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
FCF Yield %	Get a 7-Day Free Trial															3.00	8.59	2.20	9.48	11.33

Competitive Comparison of Alliance Pharma's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Alliance Pharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alliance Pharma's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alliance Pharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Alliance Pharma's FCF Yield % falls into.

Alliance Pharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Alliance Pharma's FCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	20.365	/	286.19735
	=	7.12%

Alliance Pharma's annualized FCF Yield % for the quarter that ended in Jun. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	15.259	*	2	/	269.264775
	=	11.33%

Alliance Pharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Alliance Pharma FCF Yield % Related Terms

Thank you for viewing the detailed overview of Alliance Pharma's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Alliance Pharma (LSE:APH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alliance Pharma PLC (LSE:APH) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

DVL:Germany

Address

Bath Road, Avonbridge House, Chippenham, Wiltshire, GBR, SN15 2BB

Website

https://www.alliancepharmaceuticals.com

Alliance Pharma PLC is a player in the healthcare market. The company's business includes the acquisition, marketing, and distribution of consumer healthcare and pharmaceutical products. The group operates in two segments: Consumer Healthcare brands and Prescription Medicines. It generates the majority of its revenue from the Consumer Healthcare segment. Its products include Aloclair, Biodermatin, Changmin, Decapional, Effadiane, and Fazol. The company generates maximum revenue from the Kelo-cote brand. Geographically, it derives a majority of its revenue from Europe, the Middle East, and Africa (EMEA).